🧠AI AnalysisFDA Declines Approval for Lung Cancer Drug Ivonescimab
Federal regulators have turned down an application for the investigational cancer treatment ivonescimab, pointing to a lack of statistically significant overall survival …
🧠AI AnalysisFederal regulators have turned down an application for the investigational cancer treatment ivonescimab, pointing to a lack of statistically significant overall survival …
🧠AI AnalysisFederal regulators have turned down an application for ivonescimab, an experimental lung cancer therapy invented in China and licensed by a U.S. firm, citing insufficient…
🧠Mind & Mental HealthRegulatory authorities have turned down the lung cancer therapy ivonescimab, developed by Summit Therapeutics and Akeso, citing a lack of demonstrated overall survival be…
Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.